These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

899 related articles for article (PubMed ID: 9209737)

  • 21. Successful bone marrow transplantation in sensitized aplastic anemia patients using total lymphoid irradiation for conditioning: long-term follow-up.
    Zapatero A; Marín A; López M; Martín De Vidales C; Cerezo L; Domínguez P; Pérez Torrubia A
    Hematol Oncol; 1996 Dec; 14(4):165-72. PubMed ID: 9267462
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow transplantation in children with severe aplastic anemia using a conditioning regimen containing 3 Gy of total body irradiation, cyclophosphamide with or without antithymocyte globulin.
    Inagaki J; Nagatoshi Y; Kawano Y; Saito Y; Takahashi D; Nagayama J; Shinkoda Y; Hirata H; Okamura J
    Pediatr Transplant; 2007 Mar; 11(2):180-6. PubMed ID: 17300498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Favorable effect on acute and chronic graft-versus-host disease with cyclophosphamide and in vivo anti-CD52 monoclonal antibodies for marrow transplantation from HLA-identical sibling donors for acquired aplastic anemia.
    Gupta V; Ball SE; Yi QL; Sage D; McCann SR; Lawler M; Ortin M; Freires M; Hale G; Waldmann H; Gordon-Smith EC; Marsh JC
    Biol Blood Marrow Transplant; 2004 Dec; 10(12):867-76. PubMed ID: 15570255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First-line allogeneic hematopoietic stem cell transplantation of HLA-matched sibling donors compared with first-line ciclosporin and/or antithymocyte or antilymphocyte globulin for acquired severe aplastic anemia.
    Peinemann F; Bartel C; Grouven U
    Cochrane Database Syst Rev; 2013 Jul; 2013(7):CD006407. PubMed ID: 23881658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Treatment of aplastic anemia--aims and development of the SAA 94 pilot protocol].
    Führer M; Bender-Götze C; Ebell W; Friedrich W; Kohne E
    Klin Padiatr; 1994; 206(4):289-95. PubMed ID: 7967425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.
    Keever-Taylor CA; Bredeson C; Loberiza FR; Casper JT; Lawton C; Rizzo D; Burns WH; Margolis DA; Vesole DH; Horowitz M; Zhang MJ; Juckett M; Drobyski WR
    Biol Blood Marrow Transplant; 2001; 7(11):620-30. PubMed ID: 11760150
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study.
    Shin SH; Yoon JH; Yahng SA; Lee SE; Cho BS; Eom KS; Kim YJ; Lee S; Min CK; Kim HJ; Cho SG; Kim DW; Min WS; Park CW; Lee JW
    Ann Hematol; 2013 Jun; 92(6):817-24. PubMed ID: 23318980
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BMT for severe aplastic anemia using cyclosporine.
    May WS; Sensenbrenner LL; Burns WH; Ambinder R; Carroll MP; Griffin CA; Jones RJ; Miller CB; Mellits ED; Vogelsang GB
    Bone Marrow Transplant; 1993 Jun; 11(6):459-64. PubMed ID: 8334426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with marrow transplantation or immunosuppression of childhood acquired severe aplastic anemia: a report from the EBMT SAA Working Party.
    Locasciulli A; van't Veer L; Bacigalupo A; Hows J; Van Lint MT; Gluckman E; Nissen C; McCann S; Vossen J; Schrezenmeier A
    Bone Marrow Transplant; 1990 Sep; 6(3):211-7. PubMed ID: 2252962
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term follow-up of allogeneic stem cell transplantation in patients with severe aplastic anemia after conditioning with cyclophosphamide plus antithymocyte globulin.
    Kröger N; Zabelina T; Renges H; Krüger W; Kordes U; Rischewski J; Schrum J; Horstmann M; Ayuk F; Erttmann R; Kabisch H; Zander AR
    Ann Hematol; 2002 Nov; 81(11):627-31. PubMed ID: 12454700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.
    Kahl C; Leisenring W; Deeg HJ; Chauncey TR; Flowers ME; Martin PJ; Sanders JE; Storb R
    Br J Haematol; 2005 Sep; 130(5):747-51. PubMed ID: 16115132
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Long-term outcome of acquired aplastic anaemia in children: comparison between immunosuppressive therapy and bone marrow transplantation.
    Kojima S; Horibe K; Inaba J; Yoshimi A; Takahashi Y; Kudo K; Kato K; Matsuyama T
    Br J Haematol; 2000 Oct; 111(1):321-8. PubMed ID: 11091219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bone marrow transplantation for transfused patients with severe aplastic anemia using cyclophosphamide and total lymphoid irradiation as conditioning therapy: long-term follow-up from a single center.
    Gaziev D; Giardini C; Galimberti M; Lucarelli G; Angelucci E; Polchi P; Baronciani D; Erer B; Sotti G
    Bone Marrow Transplant; 1999 Aug; 24(3):253-7. PubMed ID: 10455362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tacrolimus as an alternative to cyclosporine in the maintenance phase of immunosuppressive therapy for severe aplastic anemia in children.
    Alsultan A; Goldenberg NA; Kaiser N; Graham DK; Hays T
    Pediatr Blood Cancer; 2009 May; 52(5):626-30. PubMed ID: 19148946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Treatment of severe aplastic anemia with bone marrow transplants or with antithymocyte globulin. Evaluation of 27 patients].
    Arranz R; Steegmann JL; Fernández-Garesse D; Figuera A; Vázquez L; Fernández-Rañada JM
    Rev Clin Esp; 1989 Feb; 184(3):121-4. PubMed ID: 2655043
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Similar survival following HLA-identical sibling transplantation for standard indication in children with haematologic malignancies: a single center comparison of mobilized peripheral blood stem cell with bone marrow transplantation.
    Meisel R; Enczmann J; Balzer S; Bernbeck B; Kramm C; Schönberger S; Sinha K; Tröger A; Wernet P; Göbel U; Laws HJ; Dilloo D
    Klin Padiatr; 2005; 217(3):135-41. PubMed ID: 15858704
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy.
    Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L
    Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Indications, problems and future perspectives of bone marrow transplantation in pediatrics].
    Slavc I
    Padiatr Padol; 1992; 27(6):167-75. PubMed ID: 1484709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of response to immunosuppressive therapy with antithymocyte globulin and cyclosporine and prognostic factors for survival in patients with severe aplastic anemia.
    Chang MH; Kim KH; Kim HS; Jun HJ; Kim DH; Jang JH; Kim K; Jung CW
    Eur J Haematol; 2010 Feb; 84(2):154-9. PubMed ID: 19912311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Allogeneic bone marrow transplantation in children with severe acquired aplastic anemia. The long-term results. The Spanish Group for Bone Marrow Transplantation in Children (GETMON)].
    Muñoz Villa A; Ortega Aramburu JJ; Bureo Dacal E; Badell Serra I; Madero López L; Olive Oliveras T; Cubells Riero J; Maldonado Regalado MS; Ramírez Orellana M
    An Esp Pediatr; 1999 Jan; 50(1):29-32. PubMed ID: 10083639
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.